Trial Profile
Alpha 2 Agonists for Sedation to Produce Better Outcomes From Critical Illness (A2B Trial): A Randomised, Parallel-group, Allocation Concealed, Controlled, Open, Phase 3 Pragmatic Clinical and Cost- Effectiveness Trial With Internal Pilot
Status:
Active, no longer recruiting
Phase of Trial:
Phase III
Latest Information Update: 01 Dec 2023
Price :
$35
*
At a glance
- Drugs Clonidine (Primary) ; Dexmedetomidine (Primary) ; Propofol
- Indications Sedation
- Focus Therapeutic Use
- Acronyms A2B Trial
- 28 Nov 2023 Planned End Date changed from 31 Dec 2023 to 15 Dec 2023.
- 22 Feb 2023 Planned End Date changed from 31 Jul 2023 to 31 Dec 2023.
- 22 Feb 2023 Planned primary completion date changed from 31 Mar 2023 to 31 Oct 2023.